My Treatment Approach: Androgen Receptor Inhibitors and the Evolving Treatment Paradigm in Castration-Sensitive Prostate Cancer - Episode 1
Testing Principes and Benefits of Early Intervention in Castration-Sensitive Prostate Cancer
Key opinion leaders examine the principles and advantages of early intervention strategies for patients with castration-sensitive prostate cancer.
- Dr. Efstathiou asks Dr. Freedland:Let's start by discussing the importance of early intervention in castration-sensitive prostate cancer (CSPC). What are the potential benefits of treating patients earlier in their disease course?
- How does early intervention impact long-term outcomes and quality of life?
- What are the risks of delaying systematic treatment?
- Dr. Freedland asks Dr. Efstathiou: Discuss the significance of biomarker and genetic testing, as well as imaging, in diagnosis of patients with prostate cancer.
- Briefly review guidelines for testing (NCCN Guidelines, Prostate Cancer)
- How do these results impact patient management? (eg, prognosis, risk stratification, treatment selection)
Related Content:
